We are live on ! Find out more
CB

Chemical Bank Portfolio holdings

AUM $881M
1-Year Est. Return 4.54%
This Fund
S&P 500
This Quarter Est. Return
+3.19%
1 Year Est. Return
+4.54%
3 Year Est. Return
+36.47%
5 Year Est. Return
+51.32%
10 Year Est. Return
AUM
$556M
AUM Growth
-$6.02M
Cap. Flow
-$20.8M
Cap. Flow %
-3.75%
Top 10 Hldgs %
35.24%
Holding
297
New
12
Increased
77
Reduced
139
Closed
10

Top Buys

Rank Stock Value
1
CTSH icon
Cognizant
CTSH
+$1.37M
2
DIS icon
Walt Disney
DIS
+$783K
3
MET icon
MetLife
MET
+$759K
4
ITC
ITC HOLDINGS CORP
ITC
+$631K
5
VTRS icon
Viatris
VTRS
+$501K

Top Sells

Rank Stock Value
1
DD icon
DuPont de Nemours
DD
+$6.99M
2
XOM icon
ExxonMobil
XOM
+$3.31M
3
JNJ icon
Johnson & Johnson
JNJ
+$1.52M
4
GE icon
GE Aerospace
GE
+$1.38M
5
PG icon
Procter & Gamble
PG
+$1.18M

Sector Composition

Rank Sector Weight
1 Materials 16.78%
2 Financials 15.57%
3 Healthcare 11.97%
4 Technology 10.01%
5 Industrials 9.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
INTC icon
26
Intel
INTC
$509B
$4.42M 0.8%
171,370
-5,004
-3% -$125K
COP icon
27
ConocoPhillips
COP
$144B
$4.42M 0.8%
62,818
-41
-0.1% -$2.74K
MO icon
28
Altria Group
MO
$114B
$4.36M 0.78%
116,360
-1,842
-2% -$66.9K
MRK icon
29
Merck
MRK
$316B
$4.03M 0.73%
74,466
-19,269
-21% -$998K
MCHP icon
30
Microchip Technology
MCHP
$43.8B
$4.02M 0.72%
168,510
-860
-0.5% -$19.6K
ESRX
31
DELISTED
Express Scripts Holding Company
ESRX
$3.97M 0.71%
52,828
-127
-0.2% -$9.51K
CVS icon
32
CVS Health
CVS
$133B
$3.85M 0.69%
51,471
+2,584
+5% +$183K
FISV
33
Fiserv Inc
FISV
$29.7B
$3.75M 0.68%
132,436
+1,120
+0.9% +$32K
GILD icon
34
Gilead Sciences
GILD
$168B
$3.75M 0.67%
52,851
-971
-2% -$76.2K
SYK icon
35
Stryker
SYK
$129B
$3.72M 0.67%
45,623
+559
+1% +$44.5K
ACN icon
36
Accenture
ACN
$104B
$3.65M 0.66%
45,738
-627
-1% -$51.5K
CAT icon
37
Caterpillar
CAT
$404B
$3.61M 0.65%
36,362
-3,786
-9% -$357K
MSFT icon
38
Microsoft
MSFT
$3.66T
$3.34M 0.6%
81,513
+255
+0.3% +$9.57K
PEP icon
39
PepsiCo
PEP
$190B
$3.31M 0.6%
39,694
-115
-0.3% -$9.34K
DIS icon
40
Walt Disney
DIS
$170B
$3.3M 0.59%
41,220
+10,097
+32% +$783K
ORCL icon
41
Oracle
ORCL
$420B
$3.21M 0.58%
78,358
-14,686
-16% -$559K
VTRS icon
42
Viatris
VTRS
$20.6B
$3.2M 0.58%
65,630
+10,315
+19% +$501K
DOC icon
43
Healthpeak Properties
DOC
$14.9B
$3.15M 0.57%
89,085
-9,621
-10% -$332K
AAPL icon
44
Apple
AAPL
$4.52T
$3.07M 0.55%
160,272
-11,536
-7% -$219K
MMM icon
45
3M
MMM
$93.6B
$3.04M 0.55%
26,796
-687
-2% -$76.3K
PRU icon
46
Prudential Financial
PRU
$42.9B
$3.03M 0.54%
35,755
+4,236
+13% +$365K
ABT icon
47
Abbott
ABT
$182B
$2.74M 0.49%
71,110
-12,650
-15% -$488K
PSX icon
48
Phillips 66
PSX
$82.5B
$2.68M 0.48%
34,834
+1,586
+5% +$121K
GIS icon
49
General Mills
GIS
$19.3B
$2.67M 0.48%
51,620
-4,400
-8% -$218K
HD icon
50
Home Depot
HD
$347B
$2.66M 0.48%
33,652
-425
-1% -$33.8K

Similar funds

Chemical Bank's Q1 2014 Portfolio in Review

As of Q1 2014, Chemical Bank held 297 positions worth $556M, down 1.1% from $562M the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Chemical Bank withdrew a net $20.8M in Q1 2014, closing 10 positions and reducing 139 holdings. Its most notable exit was NCR Voyix, an estimated $921K position sold in full.

By sector, the portfolio is most concentrated in Materials at 17% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Chemical Bank opened a new position in Cognizant worth $1.38M.

  • Chemical Bank's largest Q1 2014 buy was Cognizant: 27,330 shares worth $1.38M.
  • Chemical Bank added most to Walt Disney in Q1 2014, an estimated $783K increase.
  • Chemical Bank's biggest Q1 2014 reduction was DuPont de Nemours, cutting an estimated $6.99M.
  • Chemical Bank fully exited NCR Voyix in Q1 2014, selling an estimated $921K.
  • Chemical Bank's ten largest holdings make up 35% of its $556M portfolio in Q1 2014.
  • Chemical Bank opened 12 new positions and closed 10 in Q1 2014.
  • Chemical Bank's portfolio value fell 1.1% quarter-over-quarter to $556M.

Based on Chemical Bank's 13F filing for Q1 2014, filed 13 May 2014.